금융 뉴스 허브

Brookdale (BKD): Buy, Sell, or Hold Post Q1 Earnings?

Brookdale’s 38.6% return over the past six months has outpaced the S&P 500 by 30.6%, and its stock price has climbed to $15.59 per share. This was partly due to its solid quarterly results, and the ru ...

Your 5 biggest ‘Trump account’ questions, answered

Here’s who is eligible for $1,000 in free money — and where it can be invested.

SpaceX wins wild praise, with one analyst going so far as to predict a 400% stock surge

Wall Street is using colorful language as analysts cheer major upside potential for SpaceX’s stock.

Japanese Yen: Weak against US Dollar with limited upside – NBC

National Bank of Canada ’s (NBC) Stéfane Marion and Kyle Dahms highlight the Japanese Yen (JPY) trading near multi-decade lows around 161 per USD, even as long-end yield differentials move in Japan’s ...

Cloudflare upgraded at ScotiaBank on AI traffic opportunity

EUR/GBP Price Forecast: Bearish bias persists below 0.8600

EUR/GBP trades with a positive bias on Tuesday as sellers take a breather following the recent selloff that pushed the cross to a more than one-year low. At the time of writing, EUR/GBP is trading aro ...

Rivian shares slide as EV maker to raise capital through stock offering

Here's Why You Should Hold ManpowerGroup Stock in Your Portfolio

MAN rides strong momentum as AI-driven workforce demand, digital expansion and shareholder returns support growth, but key risks remain.

3 Reasons to Avoid FFIN and 1 Stock to Buy Instead

First Financial Bankshares trades at $34.75 and has moved in lockstep with the market. Its shares have returned 12.1% over the last six months while the S&P 500 has gained 8%.

United States RealClearMarkets/TIPP Economic Optimism (MoM) came in at 45.5, above forecasts (45) in July

United States RealClearMarkets/TIPP Economic Optimism (MoM) came in at 45.5, above forecasts (45) in July

Canada Ivey Purchasing Managers Index s.a below expectations (59.1) in June: Actual (56.2)

Canada Ivey Purchasing Managers Index s.a below expectations (59.1) in June: Actual (56.2)

This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal

Crinetics Pharmaceuticals stock was surging on Tuesday after Vertex Pharmaceuticals said it had agreed to buy the biotech for $10 billion. Vertex slid 2.2%. Vertex said in a press release late Mo ...